News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Ambrx, Inc. Raises $10 Million



4/1/2009 7:44:54 AM

PE Hub -- Ambrx Inc., a La Jolla, Calif.-based developer of genetically-engineered protein therapeutics, has raised $10 million in new equity funding, according to a regulatory filing. The company previously raised around $70 million from firms like 5AM Ventures, Aravis Ventures, CMEA Capital, Maverick Capital, Versant Ventures and Tavistock Life Sciences. www.ambrx.com



comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES